Alabama
Birmingham; UCB Clinical Trial Call Center
Safety Study of Levocetirizine Dihydrochloride Oral Liquid Formulation in Children Aged 6 Months to 11 Months (BALL)
Arkansas
Hot Springs; UCB Clinical Trial Call Center
Safety Study of Levocetirizine Dihydrochloride Oral Liquid Formulation in Children Aged 6 Months to 11 Months (BALL)
Little Rock; UCB Clinical Trial Call Center
Safety Study of Levocetirizine Dihydrochloride Oral Liquid Formulation in Children Aged 6 Months to 11 Months (BALL)
Little Rock; UCB Clinical Trial Call Center
Safety Study of Levocetirizine Dihydrochloride Oral Liquid Formulation in Children Aged 6 Months to 11 Months (BALL)
California
Bakersfield; UCB Clinical Trial Call Center
Safety Study of Levocetirizine Dihydrochloride Oral Liquid Formulation in Children Aged 6 Months to 11 Months (BALL)
Crescent City; UCB Clinical Trial Call Center
Safety Study of Levocetirizine Dihydrochloride Oral Liquid Formulation in Children Aged 6 Months to 11 Months (BALL)
Huntington Beach; UCB Clinical Trial Call Center
Safety Study of Levocetirizine Dihydrochloride Oral Liquid Formulation in Children Aged 6 Months to 11 Months (BALL)
Los Angeles; UCB Clinical Trial Call Center
Safety Study of Levocetirizine Dihydrochloride Oral Liquid Formulation in Children Aged 6 Months to 11 Months (BALL)
Orange; UCB Clinical Trial Call Center
Safety Study of Levocetirizine Dihydrochloride Oral Liquid Formulation in Children Aged 6 Months to 11 Months (BALL)
Stockton; UCB Clinical Trial Call Center
Safety Study of Levocetirizine Dihydrochloride Oral Liquid Formulation in Children Aged 6 Months to 11 Months (BALL)
Colorado
Centennial; 1st International Clinical Research Center
Does your child suffer from Seasonal Allergic Rhinitis?
Georgia
Gainesville; UCB Clinical Trial Call Center
Safety Study of Levocetirizine Dihydrochloride Oral Liquid Formulation in Children Aged 6 Months to 11 Months (BALL)
Illinois
Normal; UCB Clinical Trial Call Center
Safety Study of Levocetirizine Dihydrochloride Oral Liquid Formulation in Children Aged 6 Months to 11 Months (BALL)
Minnesota
Minneapolis; Clinical Research Institute, MN
Perennial Allergic Rhinitis
Missouri
Bridgeton; UCB Clinical Trial Call Center
Safety Study of Levocetirizine Dihydrochloride Oral Liquid Formulation in Children Aged 6 Months to 11 Months (BALL)
Nebraska
Omaha; UCB Clinical Trial Call Center
Safety Study of Levocetirizine Dihydrochloride Oral Liquid Formulation in Children Aged 6 Months to 11 Months (BALL)
Ohio
Sylvania; Toledo Center for Clinical Research (TCCR)
Ragweed Allergy? Toledo Center for clinical research is seeking volunteers ages 18 to 50 with fall allergies to test an investigational allergy medication.
Oklahoma
Oklahoma City; UCB Clinical Trial Call Center
Safety Study of Levocetirizine Dihydrochloride Oral Liquid Formulation in Children Aged 6 Months to 11 Months (BALL)
South Carolina
Barnwell; UCB Clinical Trial Call Center
Safety Study of Levocetirizine Dihydrochloride Oral Liquid Formulation in Children Aged 6 Months to 11 Months (BALL)
Spartanburg; UCB Clinical Trial Call Center
Safety Study of Levocetirizine Dihydrochloride Oral Liquid Formulation in Children Aged 6 Months to 11 Months (BALL)
Tennessee
Kingsport; UCB Clinical Trial Call Center
Safety Study of Levocetirizine Dihydrochloride Oral Liquid Formulation in Children Aged 6 Months to 11 Months (BALL)
Texas
Dallas; UCB Clinical Trial Call Center
Safety Study of Levocetirizine Dihydrochloride Oral Liquid Formulation in Children Aged 6 Months to 11 Months (BALL)
El Paso; UCB Clinical Trial Call Center
Safety Study of Levocetirizine Dihydrochloride Oral Liquid Formulation in Children Aged 6 Months to 11 Months (BALL)
San Antonio; UCB Clinical Trial Call Center
Safety Study of Levocetirizine Dihydrochloride Oral Liquid Formulation in Children Aged 6 Months to 11 Months (BALL)
Sugarland; UCB Clinical Trial Call Center
Safety Study of Levocetirizine Dihydrochloride Oral Liquid Formulation in Children Aged 6 Months to 11 Months (BALL)
Virginia
Richmond; UCB Clinical Trial Call Center
Safety Study of Levocetirizine Dihydrochloride Oral Liquid Formulation in Children Aged 6 Months to 11 Months (BALL)
